Edward Lee Carter։ Stroke Prevention Starts in the Emergency Department – but Doesn’t End There
Edward Lee Carter, Clinical Pharmacist Practitioner at U.S. Department of Veterans Affairs, shared Emergency Medicine News’s post on LinkedIn about a recent article by Baldwin, published in Emergency Medicine News, adding:
”One of the most important moments in stroke prevention may occur in the Emergency Department.
Atrial fibrillation is increasingly encountered during acute care encounters, but initiating anticoagulation is often only the beginning of the challenge.
In real-world practice, the long-term success of anticoagulation frequently depends on what happens after discharge:
- patient understanding
- renal function follow-up
- medication affordability/access
- transitions of care
- peri-procedural planning
- coordination between clinicians
Underdosing DOACs ‘for safety’ when criteria are not met is another important issue that deserves continued attention, as inappropriate dose reduction may reduce efficacy without meaningfully improving outcomes.
Anticoagulation management is rarely just about selecting a drug.
It is about building a safe, understandable, sustainable plan for the patient.
That is where interdisciplinary care—including physicians, pharmacists, nurses, and patients themselves—can make a tremendous difference.”
Quoting Emergency Medicine News’s post:
”Atrial fibrillation is rising in the ED and early anticoagulation is one of the most impactful ways to prevent stroke. Current guidelines emphasize CHA₂DS₂‑VASc–based decisions, DOACs over warfarin, and correcting bleeding risks rather than withholding therapy.
Avoid underdosing (it raises stroke risk nearly 5 times), ensure patients understand their regimen, and remember: all cardioversion patients need at least 4 weeks of anticoagulation, regardless of method or timing.
ED clinicians are uniquely positioned to start stroke prevention at the moment it matters most.”
Title: Anticoagulation Strategies for Stroke Prevention in Atrial Fibrillation
Authors: Baldwin, Kendall PharmD Candidate, Hile, Kaitlin PharmD, BCCP, Hile, Garrett PharmD, BCEMP, BCCCP, Howington, Gavin T. PharmD, BCCCP, BCEMP

Stay updated on all scientific advances with Hemostasis Today.
-
May 8, 2026, 17:14Hayder Kadhim: Determinants and Outcomes of OAC Discontinuation in Atrial Fibrillation
-
May 8, 2026, 17:11Drazen Perkov: Complication Management in Endovascular Thrombectomy
-
May 8, 2026, 17:07Basel Saber: New Evidence on Stroke Prevention in Post-Operative Atrial Fibrillation
-
May 8, 2026, 17:00Adriana Skafi: Case Report on Catastrophic Antiphospholipid Syndrome
-
May 8, 2026, 16:43Panagiotis Iliakis: The ANDAMAN Trial and the Challenge of Aspirin Resistance
-
May 8, 2026, 16:36Ali AlBahar: Why Blood Groups Matter
-
May 8, 2026, 16:27Tanmay Banerjee: Laboratory Error Safety in Hematology Testing
-
May 8, 2026, 16:26Nadishani Ratnayake: Supporting Safer Anticoagulation Care With Digital Tools
-
May 8, 2026, 16:15Jim Hoffman: Thrombomodulin as a Key Regulator of Coagulation and Inflammation